When Amina Balogun (not real name) was admitted to Lagos University Teaching Hospital for systemic lupus erythematosus, she didn’t know it would become a fight against relentless infections.
She received multiple courses of antibiotics, including ceftriaxone, metronidazole, piperacillin/tazobactam, levofloxacin, meropenem, gentamicin, and amikacin, yet the infections remained relentless and more severe.
After about two months of admission, Balogun’s condition deteriorated and she developed severe sepsis that was unresponsive to even last-resort antibiotics such as meropenem and tigecycline.